Add BrightSurf on Google Email

Medical University of South Carolina


Breakthrough drug combination remains safe and effective in patients with cystic fibrosis after four years

A multicenter study found that patients with cystic fibrosis can safely take a dual combination of CF modulator drugs for four years while maintaining previously achieved clinical improvement. This breakthrough therapy has improved the quality and length of patients' lives, with some even seeing a 15% increase in lung function.

SourceMedical University of South Carolina·JournalJournal of Cystic Fibrosis·TypeRandomized controlled/clinical trial·DateMar 15, 2023

Team of sister scientists identifies a possible genetic culprit for uterine corpus endometrial cancer

A team of scientists has identified Myo5b as a potential genetic driver of uterine corpus endometrial cancer (UCEC), a fourth deadliest cancer in women. Elevated levels of Myo5B were found in UCEC samples, suggesting its role in transporting nutrient-absorbing transporters to the surface of cancer cells.

SourceMedical University of South Carolina·JournalPLOS ONE·TypeData/statistical analysis·DateMar 14, 2023

The fat tax: Long-term, systemic antibiotic use for the treatment of adolescent acne can promote fat accumulation

Researchers found that long-term antibiotic use during adolescence disrupts the healthy gut microbiome, leading to changes in liver metabolism that promotes central fat accumulation. The study suggests that antibiotic treatment may have lasting detrimental effects on liver metabolism and promote adiposity.

SourceMedical University of South Carolina·JournalAmerican Journal Of Pathology·TypeExperimental study·DateMar 13, 2023

New approach to improving clinical trial enrollment and diversity

A new approach by the Medical University of South Carolina aims to increase clinical trial participation, especially from diverse populations. By making patients eligible for research opportunities by default, while allowing opt-out, the team saw a significant increase in potential participants.

SourceMedical University of South Carolina·JournalJournal of Clinical and Translational Science·TypeObservational study·DateMar 8, 2023

Hollings researchers develop small molecule to stimulate natural killer cells against neuroblastoma

Hollings researchers create small molecule that targets CD38 enzyme activity, stimulating proliferation of natural killer cells and enhancing anti-cancer activity. The compound has potential as an adjuvant therapy to boost effects of existing treatments and reduce resistance to monoclonal antibodies.

SourceMedical University of South Carolina·JournalChemical Science·TypeExperimental study·DateFeb 28, 2023

School-based wellness initiative shown to reduce average student BMI

A school-based wellness initiative led by MUSC's Boeing Center for Children's Wellness has been shown to reduce the average student BMI over time. The program, which targets policy, systems and environmental change, uses evidence-based strategies such as physical activity, nutrition and social-emotional wellness.

SourceMedical University of South Carolina·JournalJournal of School Health·TypeExperimental study·DateFeb 28, 2023

Discovery of cancer-associated fibroblast origin gives new direction for pancreatic cancer

Researchers at MUSC Hollings Cancer Center discovered the cellular origin of normal pancreatic fibroblasts and cancer-associated fibroblasts, which play a key role in tumor progression. The findings suggest that targeting cancer-associated fibroblasts holds exciting potential for therapeutic benefits.

SourceMedical University of South Carolina·JournalNature Communications·TypeExperimental study·DateJan 20, 2023

BRIGHT outlook: A brief cognitive behavioral therapy appears promising for head and neck cancer survivors suffering from body-image distress

A new brief tele-cognitive behavioral therapy, BRIGHT, shows promise in reducing body-image distress among head and neck cancer survivors. The trial found that levels of body-image distress fell significantly for those who received the therapy compared to standard survivorship education.

SourceMedical University of South Carolina·JournalJAMA Otolaryngology–Head & Neck Surgery·DateJan 5, 2023

When combined, a novel LSD1 inhibitor and an existing therapy enhance each other’s anti-cancer effects

Medical University of South Carolina researchers develop a novel LSD1 inhibitor that shows early promise at fighting neuroblastoma when paired with bortezomib. The combination boosts anti-tumor response and is a viable strategy for targeting high-risk MYCN-amplified neuroblastoma.

SourceMedical University of South Carolina·JournalEuropean Journal of Medicinal Chemistry·TypeExperimental study·DateDec 13, 2022

Of mice and men: Treating acne with systemic antibiotics can have unintended consequences on the maturing skeleton during adolescence

Long-term use of systemic antibiotics can alter the gut microbiome, leading to reduced bone mass accrual and impaired skeletal maturation. Researchers found that minocycline therapy causes changes to the gut microbiome, disrupting normal communication between the liver and small intestine.

SourceMedical University of South Carolina·JournalJCI Insight·DateNov 22, 2022

Treatment guidelines for children hospitalized with COVID-19 were rapidly but not completely followed

A study of 18,364 children hospitalized with COVID-19 found that pediatricians prescribed medications in accordance with guidelines in only 55-82% of cases. The use of recommended medications quickly increased after national guidelines were released in 2020, but compliance remained lower than expected.

SourceMedical University of South Carolina·JournalPEDIATRICS·TypeObservational study·DateNov 16, 2022

Changing the face of innovation

A new MUSC initiative aims to increase the number of women entrepreneurs by offering coaching, mentoring, and training opportunities. The program will pair trainees with successful biomedical entrepreneurs, providing valuable role models and guidance. By addressing gender inequity in STEM fields, STEM-CREW seeks to advance the careers ...

Pediatric cardiologists uncover possible cause of racial disparity affecting congenital heart disease

A recent study by pediatric cardiologists has found that certain maternal health conditions can partially explain the racial disparities in congenital heart disease outcomes. The research assessed over 8,000 infant and mother records from diverse populations and identified placental and metabolic syndromes as contributing factors.

SourceMedical University of South Carolina·JournalThe Journal of Pediatrics·TypeData/statistical analysis·DateAug 26, 2022

Researcher looks at molecular changes for clues to disparities in breast cancer outcomes

A recent study found associations between socioeconomic stressors and specific N-glycosylation patterns in Black and White women, suggesting that molecular markers may be linked to socioeconomic status. The research also identified differences in glycosylation patterns in normal breast tissue based on body mass index (BMI) and ancestry.

SourceMedical University of South Carolina·JournalFrontiers in Oncology·DateAug 24, 2022

With radically improved pain control, bone marrow donors can gift stem cells without worry of undue side effects or opioid use

Bone marrow donors can now receive significantly reduced opioid medication during and after the donation procedure, resulting in a more comfortable experience. The new pain control method, using regional anesthesia, drastically decreased opioid usage from 84% to 23% among patients.

SourceMedical University of South Carolina·JournalFrontiers in Medicine·TypeExperimental study·DateJul 18, 2022

Problems in the powerhouse: Excessive degradation of mitochondria found to be a tipping point from normal, beneficial alcohol metabolism to alcoholic liver disease

Research finds that excessive mitochondrial damage caused by alcohol exposure can lead to chronic liver disease. Mitochondrial depolarization triggers mitophagy, a process removing damaged mitochondria; however, constant removal causes additional liver tissue damage.

Vaccinia virus MacGyvers a makeshift tool to repair its DNA, exposing a vulnerability that could be targeted

Researchers at Medical University of South Carolina found that blocking the enzyme polymerase reduces the virus's ability to multiply. This discovery exposes an Achilles' heel that could be targeted with a therapeutic. Polymerase is a key tool for DNA replication and repair, making the virus vulnerable to disruption.

SourceMedical University of South Carolina·JournalJournal of Virology·TypeExperimental study·DateMay 16, 2022

Shrinking gap in surgical safety outcomes benefits older black patients in South Carolina

A recent study by MUSC shows that quality improvement efforts have decreased complications for all patients and narrowed the gap in surgical outcomes between black and white patients. The research, led by Dr. Thomas Curran, analyzed data from over 30,000 patients who underwent surgery between 2015 and 2020.

SourceMedical University of South Carolina·JournalJournal of the American College of Surgeons·TypeData/statistical analysis·DateApr 26, 2022

Providing a potential treatment option to infants where there is none

A study led by MUSC researchers found that inhibiting the complement system with CR2Crry can prevent long-term brain damage and improve outcomes in premature infants with germinal matrix hemorrhage. The treatment has shown improved survival, weight gain, reduced brain injury, and enhanced motor and cognitive performances.

SourceMedical University of South Carolina·JournalInternational Journal of Molecular Sciences·DateApr 20, 2022

Study of data from NASA, ESA and Russian space agency explores effects of extended spaceflight on brain

A study of NASA, ESA, and Russian space agency data found that extended spaceflight leads to changes in the brain's perivascular spaces. The research, led by Medical University of South Carolina scientists, used MRI scans to evaluate brain changes before and after six months on the International Space Station.

SourceMedical University of South Carolina·JournalProceedings of the National Academy of Sciences·TypeData/statistical analysis·DateApr 12, 2022

Living in a microbial world: The healthy oral microbiome contributes to jaw bone health by influencing immune cell interactions with bone cells

A recent study found that a subset of immune cells within the alveolar bone marrow were activated by the presence of commensal oral microbes, leading to increased osteoclast-mediated bone resorption and bone loss. Reducing the burden of commensal microbes through oral antiseptic rinses can help protect against alveolar bone loss.

SourceMedical University of South Carolina·JournalJCI Insight·DateFeb 16, 2022